GVK BIO performs general toxicology studies for the safety evaluation of pharmaceutical, biopharmaceutical, veterinary, chemical, agrochemical and consumer products. Through our toxicology studies, we help our clients characterize the potential extent of injury that an NCE/ biologic could produce at varied dosages and predict the consequences of such injury to understand the risk / benefit equation of the drug candidate in terms of toxicity and efficacy. We have the ability to conduct non-GLP toxicology studies catering to customer needs.
GVK BIO has an extensive track record in the design, performance and interpretation of pre-clinical investigative, mechanistic and exploratory/discovery toxicology programs. We offer a range of exploratory in vitro and in vivo preclinical safety and toxicity services. All our studies are conducted with IAEC approved protocols under the supervision of trained veterinarians/pathologist. Toxicology studies are supported by in house histopathology and clinical pathology.
Choosing a lead compound from the pool of candidates does not need to be so time consuming or expensive. Whether you are in the exploratory candidate selection stage in pharmaceuticals or agrochemicals, efficient use of exploratory testing services can be your simple answer to a challenging decision. GVK BIO’s scientific team has extensive experience in this regard.